albuterol mdi
albuterol mdi: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ARS Pharmaceuticals, Inc. (SPRY)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | Phase 2 |
Clinical Trials (1)
A Phase 2, Single-Dose, Randomized, Active and Placebo Controlled, Four-Period, Cross-Over Study of the Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 or Albuterol in Subjects With Persistent Asthma
Frequently asked questions
Who is developing albuterol mdi?
albuterol mdi is being developed by ARS Pharmaceuticals, Inc..
How many clinical trials involve albuterol mdi?
BioSniper tracks 1 clinical trial involving albuterol mdi.
Analyze ARS Pharmaceuticals, Inc. & albuterol mdi with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company